| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Adult cardiac stem cells are multipotent and support myocardial regeneration.
|
Cell
|
2003
|
18.09
|
|
2
|
Chimerism of the transplanted heart.
|
N Engl J Med
|
2002
|
8.69
|
|
3
|
Human cardiac stem cells.
|
Proc Natl Acad Sci U S A
|
2007
|
7.76
|
|
4
|
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.
|
Proc Natl Acad Sci U S A
|
2005
|
4.13
|
|
5
|
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.
|
Circ Res
|
2004
|
4.13
|
|
6
|
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function.
|
Proc Natl Acad Sci U S A
|
2005
|
3.64
|
|
7
|
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.
|
Circ Res
|
2004
|
3.39
|
|
8
|
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function.
|
Circ Res
|
2008
|
3.07
|
|
9
|
Bone marrow cells adopt the cardiomyogenic fate in vivo.
|
Proc Natl Acad Sci U S A
|
2007
|
3.06
|
|
10
|
Cardiomyogenesis in the adult human heart.
|
Circ Res
|
2010
|
2.79
|
|
11
|
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene.
|
Circ Res
|
2006
|
2.71
|
|
12
|
Clonality of mouse and human cardiomyogenesis in vivo.
|
Proc Natl Acad Sci U S A
|
2009
|
2.60
|
|
13
|
Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure.
|
Circ Res
|
2003
|
2.45
|
|
14
|
Human cardiac stem cell differentiation is regulated by a mircrine mechanism.
|
Circulation
|
2011
|
2.38
|
|
15
|
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan.
|
Circ Res
|
2008
|
2.31
|
|
16
|
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction.
|
Circulation
|
2009
|
2.30
|
|
17
|
Identification of a coronary vascular progenitor cell in the human heart.
|
Proc Natl Acad Sci U S A
|
2009
|
2.23
|
|
18
|
Notch1 regulates the fate of cardiac progenitor cells.
|
Proc Natl Acad Sci U S A
|
2008
|
2.22
|
|
19
|
Formation of large coronary arteries by cardiac progenitor cells.
|
Proc Natl Acad Sci U S A
|
2008
|
2.05
|
|
20
|
The young mouse heart is composed of myocytes heterogeneous in age and function.
|
Circ Res
|
2007
|
1.69
|
|
21
|
Nuclear targeting of Akt enhances ventricular function and myocyte contractility.
|
Circ Res
|
2005
|
1.62
|
|
22
|
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.
|
Circulation
|
2009
|
1.62
|
|
23
|
Concise review: stem cells, myocardial regeneration, and methodological artifacts.
|
Stem Cells
|
2006
|
1.34
|
|
24
|
Spontaneous calcium oscillations regulate human cardiac progenitor cell growth.
|
Circ Res
|
2009
|
1.32
|
|
25
|
bcl-2 overexpression promotes myocyte proliferation.
|
Proc Natl Acad Sci U S A
|
2002
|
1.22
|
|
26
|
Cardiac stem cells and myocardial disease.
|
J Mol Cell Cardiol
|
2008
|
1.18
|
|
27
|
Myocardial aging--a stem cell problem.
|
Basic Res Cardiol
|
2005
|
1.17
|
|
28
|
Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart.
|
Circ Res
|
2009
|
1.06
|
|
29
|
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.
|
Basic Res Cardiol
|
2013
|
0.99
|
|
30
|
Effects of sildenafil on the gastrocnemius and cardiac muscles of rats in a model of prolonged moderate exercise training.
|
PLoS One
|
2013
|
0.86
|
|
31
|
The human heart: a self-renewing organ.
|
Clin Transl Sci
|
2008
|
0.86
|
|
32
|
The telomere-telomerase axis and the heart.
|
Antioxid Redox Signal
|
2006
|
0.86
|
|
33
|
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease?
|
Cardiovasc Hematol Agents Med Chem
|
2010
|
0.84
|
|
34
|
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors.
|
Curr Drug Targets
|
2015
|
0.75
|